We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

101 hedge funds and large institutions have $129M invested in Tvardi Therapeutics in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more call options, than puts

Call options by funds: $1.78M | Put options by funds: $583K

167% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 12

35% more capital invested

Capital invested by funds: $95.5M → $129M (+$33.4M)

35% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 23

25% more funds holding

Funds holding: 81 → 101 (+20)

1.41% more ownership

Funds ownership: 0% → 1.41% (+1.4%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
101
Holders Change
+20
Holders Change %
+24.69%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
32
Increased
31
Reduced
23
Closed
12
Calls
$1.78M
Puts
$583K
Net Calls
+$1.19M
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
+$7.92M
2
EAM
EverPoint Asset Management
Connecticut
+$2.67M
3
NC
Nexthera Capital
New York
+$2.23M
4
EI
EAM Investors
California
+$2.14M
5
BIT
BlackRock Institutional Trust
California
+$1.81M

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$2.33M
2
Renaissance Technologies
Renaissance Technologies
New York
-$2.07M
3
OM
Opaleye Management
Massachusetts
-$1.78M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$1.05M
5
Morgan Stanley
Morgan Stanley
New York
-$897K
Name Holding Trade Value Shares
Change 		Change in
Stake
NPC
26
National Planning Corporation
California
$1.01M +$24.1K +75 +4%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$976K -$59.4K -185 -6%
Ameriprise
28
Ameriprise
Minnesota
$969K +$930K +2,898 New
BIM
29
BlackRock Investment Management
Delaware
$868K -$9.95K -31 -1%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$845K +$811K +2,528 New
Squarepoint
31
Squarepoint
New York
$820K +$787K +2,452 New
SKK
32
Shepherd Kaplan Krochuk
Massachusetts
$812K -$662K -2,064 -46%
Morgan Stanley
33
Morgan Stanley
New York
$671K -$897K -2,794 -58%
Janney Montgomery Scott
34
Janney Montgomery Scott
Pennsylvania
$643K +$141K +440 +30%
Barclays
35
Barclays
United Kingdom
$620K +$594K +1,850 +46,250%
PPA
36
Parametric Portfolio Associates
Washington
$536K +$514K +1,603 New
EIM
37
Essex Investment Management
Massachusetts
$516K +$495K +1,541 New
Russell Investments Group
38
Russell Investments Group
United Kingdom
$404K +$384K +1,196 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$402K -$10.6K -33 -3%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$365K +$351K +1,093 New
BWP
41
Baldwin Wealth Partners
Massachusetts
$356K -$8.99K -28 -3%
TA
42
Teachers Advisors
New York
$310K +$22.8K +71 +8%
EP
43
Elkfork Partners
Oregon
$296K +$284K +885 New
Goldman Sachs
44
Goldman Sachs
New York
$282K +$23.7K +74 +10%
VEA
45
Virtus ETF Advisers
New York
$272K +$261K +814 New
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$266K +$262K +815 +16,300%
Charles Schwab
47
Charles Schwab
California
$257K – – –
GHCM
48
Glen Harbor Capital Management
California
$244K +$234K +729 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$236K +$8.66K +27 +4%
CG
50
Cutler Group
California
$234K +$195K +607 +646%
1
2
3 4 5

TVRD Hedge Fund Activity: Q4 2016 in Review

101 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q4 2016, worth a combined $129M — up 35% from $95.5M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new TVRD positions and 12 closed out — a net gain of 20 holders — while 31 added to existing stakes and 23 trimmed.

The largest buyer was Disciplined Growth Investors, opening a new position worth an estimated $7.92M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.33M.

  • 101 institutional investors held Tvardi Therapeutics (TVRD) as of Q4 2016, up from 81 in Q3 2016.
  • Funds reported $129M of Tvardi Therapeutics stock for Q4 2016, up 35% quarter-over-quarter.
  • 32 funds opened new Tvardi Therapeutics positions in Q4 2016 and 12 closed out, a net change of +20 holders.
  • The largest Tvardi Therapeutics buyer in Q4 2016 was Disciplined Growth Investors, an estimated $7.92M added.
  • The largest Tvardi Therapeutics seller in Q4 2016 was BlackRock Fund Advisors, an estimated $2.33M sold.

Based on aggregated 13F filings for Q4 2016.